1887
  1. Home
  2. A-Z Publications
  3. Global Cardiology Science and Practice
  4. Volume 2015, Issue 3
  5. Article
Volume 2015, Issue 3
  • ISSN: 2305-7823
  • EISSN:

Abstract

Given the increasing numbers of cardiac device implantations worldwide, it is important to determine whether permanent endocardial leads across the tricuspid valve can promote tricuspid regurgitation (TR). Virtually all current data is retrospective, and indicates a signal of TR being increased after permanent lead implantation. However, the precise incidence of moderate or greater TR post-procedure, the exact mechanisms (mechanical, traumatic, functional), and the hemodynamic burden and clinical effects of this putative increase in TR, remain uncertain. We have therefore designed a multicenter, international, prospective study of 300 consecutive patients (recruitment completed, baseline data presented) who will undergo echocardiography and clinical assessment prior to, and at 1-year post device insertion. This prospective study will help determine whether cardiac device-associated TR is real, what are its potential mechanisms, and whether it has an important clinical impact on cardiac device patients.

© 2015 Dokainish, Elbarasi, Masiero, Van de Heyning, Brambatti, Ghazal, AL-Maashani, Capucci, Buikema, Leong, Shivalkar, Saenen, Miljoen, Morillo, Divarakarmenon, Amit, Ribas, Brautigam, Baiocco, Maolo, Romandini, Maffei, Connolly, Healey, licensee Bloomsbury Qatar Foundation Journals.
Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2015.41
2015-10-17
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2015/3/gcsp.2015.41.html?itemId=/content/journals/10.5339/gcsp.2015.41&mimeType=html&fmt=ahah

References

  1. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011; 34::1013–1027.
     [Google Scholar]
  2. Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States:1993–2006. Pacing Clin Electrophysiol. 2010; 33::705–711.
     [Google Scholar]
  3. Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, Conyers del M, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013; 10::e59–e65.
     [Google Scholar]
  4. Paniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol. 1991; 82:, 1130-2, A9.
     [Google Scholar]
  5. De Cock CC, Vinkers N, van Campe LC, Verhorst PM, Visser CA. Long-term outcome of patients with multiple (>3) noninfected transvenous leads: a clinical and echographic study. Pacing Clin Electrophysiolog. 2000; 23::423–426.
     [Google Scholar]
  6. Klutstein M, Balkin J, Butnaru A, Ilan M, Lahad A, Rosenmann D. Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol. 2009; 32:Suppl 1:S135–S137.
     [Google Scholar]
  7. Webster G, Margossian R, Alexander ME, Cecchin F, Triedman JK, Walsh EP, Berul CI. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiology. 2008; 21::65–68.
     [Google Scholar]
  8. Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr. 2008; 21::284–287.
     [Google Scholar]
  9. Sadreddini M, Haroun M, Buikema L, Morillo C, Ribas S, Divarakaramenon S, Connolly SJ, Nieuwlaat R, Lonn EM, Healey JS, Dokainish H. Tricuspid valve regurgitation induced by temporary or permanent endocardial lead insertion, and the impact of cardiac resynchronization therapy. Open Cardiovasc Med Journal. 2014; 8::83–87.
     [Google Scholar]
  10. Al-Bawardy R, Krishnaswamy A, Rajeswaran J, Bhargava M, Wazni O, Wilkoff B, Tuzcu EM, Martin D, Thomas J, Blackstone E, Kapadia S. Tricuspid regurgitation and implantable devices. Pacing Clin Electrophysiol. 2015; 38::259–266.
     [Google Scholar]
  11. Kucukarslan N, Kirilmaz A, Ulusoy E, Yokusoglu M, Gramatnikovski N, Ozal E, Tatar H. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads. J Card Surg. 2006; 21::391–394.
     [Google Scholar]
  12. Leibowitz DW, Rosenheck S, Pollak A, Geist M, Gilon D. Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study. Cardiology. 2000; 93::74–77.
     [Google Scholar]
  13. Huang TY, Baba N. Cardiac pathology of transvenous pacemakers. Am Heart Journal. 1972; 83::469–474.
     [Google Scholar]
  14. Chen TE, Wang CC, Chern MS, Chu JJ. Entrapment of permanent pacemaker lead as the cause of tricuspid regurgitation. Circ J. 2007; 71::1169–1171.
     [Google Scholar]
  15. Wen-Zong L, Liang M. Severe tricuspid valve regurgitation due to perforation by permanent pacemaker lead. J Card Surg. 2011; 26::555–556.
     [Google Scholar]
  16. Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, Weinert L, Maffessanti F, Jeevanandam V, Mor-Avi V, Lang RM. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014; 7::337–347.
     [Google Scholar]
  17. Alizadeh A, Sanati HR, Haji-Karimi M, Yazdi AH, Rad MA, Haghjoo M, Emkanjoo Z. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing. Europace. 2011; 13::1587–1590.
     [Google Scholar]
  18. Vaturi M, Kusniec J, Shapira Y, Nevzorov R, Yedidya I, Weisenberg D, Monakier D, Strasberg B, Sagie A. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr. 2010; 11::550–553.
     [Google Scholar]
  19. Iskandar SB, Jackson A, Fahrig S, Mechleb BK, Garcia ID. Tricuspid valve malfunction and ventricular pacemaker lead: Case report and review of the literature. Echocardiography. 2006; 23::692–697.
     [Google Scholar]
  20. Nath J, Foster E, Heidenreich PA. Impact of Tricuspid regurgitation on long-term survival. J Am Coll Cardiology. 2004; 43::405–409.
     [Google Scholar]
  21. Al-Mohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defibrillator. J Am Soc Echocardiogr. 2012; 25::245–252.
     [Google Scholar]
  22. Fazio S, Carlomagno G. The importance of tricuspid regurgitation and right ventricular overload in ICD/CRT recipients: beside the left, beyond the left. Pacing Clin Electrophysiol. 2011; 34::1181–1184.
     [Google Scholar]
  23. Höke U, Auger D, Thijssen J, Wolterbeek R, van der Velde ET, Holman ER, Schalij MJ, Bax JJ, Delgado V, Marsan NA. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart. 2014; 100::960–968.
     [Google Scholar]
  24. Seo Y, Ishizu T, Nakajima H, Sekiguchi Y, Watanabe S, Aonuma K. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J. 2008; 72::1465–1470.
     [Google Scholar]
  25. Nazmul MN, Cha YM, Lin G, Asirvatham SJ, Powell BD. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation. Europace. 2013; 15::409–413.
     [Google Scholar]
  26. Pfannmueller B, Hirnle G, Seeburger J, Davierwala P, Schroeter T, Borger MA, Mohr FW. Tricuspid valve repair in the presence of a permanent ventricular pacemaker lead. Eur J Cardiothorac Surg. 2011; 39::657–661.
     [Google Scholar]
  27. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ. Recommendations for Evaluating of the Severity of Native Valvular Regurgitation with Two-Dimensional and Doppler Echocardiography. J Am Soc of Echocardiography. 2003; 16::777–802.
     [Google Scholar]
  28. Rahko PS. Prevalence of regurgitant murmurs in patients with valvular regurgitation detected by Doppler echocardiography. Ann Internal medicine. 1989; 111::466–472.
     [Google Scholar]
  29. Grossman G, Stein M, Kochs M, Hoher M, Koenig W, Hombach V, Giesler M. Comparison of the proximal flow convergence method and the jet area method for the assessment of the severity of tricuspid regurgitation. Eur Heart J. 1998; 19::652–659.
     [Google Scholar]
  30. Shapira Y, Porter A, Wurzel M, Vaturi Sagie A. Evaluation of tricuspid regurgitation severity: echocardiographic and clinical correlation. J Am Soc Echocardiogr. 1998; 11::652–659.
     [Google Scholar]
  31. Rivera JM, Vandervoort P, Mele D, Weyman A, Thomas JD. Value of proximal regurgitant jet size in tricuspid regurgitation. Am Heart J. 1996; 131::742–747.
     [Google Scholar]
  32. Tribouilloy CM, Enriquiez-Sarano M, Bailey KR, Tajik AJ, Seward JB. Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study. J Am Cardiol. 2000; 36::472–478.
     [Google Scholar]
  33. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013; 128::944–953.
     [Google Scholar]
  34. Auricchio A, Delnoy PP, Regoli F, Seifert M, Markou T, Butter C, collaborative study group . First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients. Europace. 2013; 15::1191–1197.
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2015.41
Loading
Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and design
Global Cardiology Science and Practice 2015, 41 (2015); https://doi.org/10.5339/gcsp.2015.41
/content/journals/10.5339/gcsp.2015.41
/content/journals/10.5339/gcsp.2015.41
Loading

Data & Media loading...

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error